Welcome to our dedicated page for Ardent Health news (Ticker: ARDT), a resource for investors and traders seeking the latest updates and insights on Ardent Health stock.
Ardent Health, Inc. (NYSE: ARDT) is a healthcare company in the medical care facilities sector that operates 30 acute care hospitals and approximately 280 sites of care across six states. Its news flow provides insight into how the company manages hospital operations, finances and growth initiatives in growing mid-sized urban communities in the United States.
News about Ardent Health frequently centers on its quarterly earnings releases, where the company reports total revenue, net income or net loss attributable to Ardent Health, and non-GAAP measures such as Adjusted EBITDA and Adjusted EBITDAR. These releases also present operating statistics, including admissions, adjusted admissions, inpatient and outpatient surgeries, total surgeries, emergency room visits and net patient service revenue per adjusted admission. Commentary in these reports discusses factors such as demand trends, professional fee expenses, payor denials and accounting estimate changes.
Investors following ARDT news will also see announcements about financial guidance, where Ardent Health provides ranges for full-year total revenue, net income attributable to the company, Adjusted EBITDA, rent expense payable to REITs, diluted earnings per share, adjusted admissions growth, net patient service revenue per adjusted admission growth and capital expenditures. The company’s releases explain that this guidance is based on current plans and expectations and is subject to risks and uncertainties.
Other news items include capital structure updates, such as the amendment and extension of its term loan facility and asset-based lending credit agreement, and the authorization of a $50.0 million stock repurchase program by its board of directors. Ardent Health also issues releases about participation in healthcare and investor conferences, leadership changes and the appointment of executives to roles focused on development and strategic growth.
This ARDT news page aggregates these announcements so readers can review Ardent Health’s earnings reports, guidance updates, financing actions, governance developments and conference participation in one place.
Ardent Health (NYSE:ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, after market close.
The company will host a conference call and webcast on Wednesday, August 6, 2025, at 10 a.m. ET to discuss the results. The webcast and presentation materials will be available on the company's investor relations website. A replay will be accessible through August 20, 2025.
Ardent Health Partners (NYSE: ARDT) announced that its board of directors has approved a corporate name change to Ardent Health, Inc., effective June 3, 2025. The healthcare provider, which operates in growing mid-sized urban communities across the U.S., is aligning its legal name with its commonly used brand identity "Ardent Health". The name change will not affect the company's NYSE trading symbol (ARDT), CUSIP number, or stockholder rights.
Ardent Health (NYSE: ARDT) has appointed Chris Schoeplein as its new chief development officer to spearhead the company's strategic growth initiatives. Schoeplein, who previously served as senior vice president at Kaufman Hall's mergers and acquisitions practice, brings nearly two decades of healthcare strategy and development experience to the role.
In his new position, Schoeplein will be responsible for leading development efforts across Ardent's existing markets and supporting expansion into new regions. His key responsibilities include driving growth in inpatient and outpatient care settings through acquisitions, partnerships, and joint ventures, while also overseeing due diligence, market intelligence, and integration planning.
The appointment comes at what CEO Marty Bonick describes as a "pivotal time" in Ardent's growth journey, as the company aims to scale its consumer-centric platform and extend its joint venture model.Ardent Health (NYSE: ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has announced its participation in two major investor conferences in May 2025:
- Bank of America Securities 2025 Health Care Conference in Las Vegas (May 13-14), featuring a presentation on May 14 at 11:40 a.m. ET
- 2025 RBC Capital Markets Global Healthcare Conference in New York City (May 20), including a fireside chat at 8:00 a.m. ET
Live audio webcasts will be available on Ardent Health's investor relations website with 90-day replay access. Management will also conduct one-on-one meetings with registered investors at both conferences.
Ardent Health (NYSE: ARDT) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on Wednesday, May 7, 2025, at 10:00 a.m. ET to discuss the results and conduct a Q&A session.
The webcast and presentation materials will be accessible through the Investor Relations section at ir.ardenthealth.com. Participants are advised to register 15 minutes before the scheduled start time. The teleconference replay will be available until May 21, 2025.
Ardent Health (NYSE: ARDT) has announced key leadership changes, appointing Dave Caspers as chief operating officer to oversee operations across 30 hospitals and 280 sites of care in six states. Caspers, formerly vice president of omnichannel operations at Walmart Health, brings extensive experience in retail healthcare and health system operations.
The company also announced three senior leadership promotions: Anika Gardenhire elevated to chief digital and transformation officer, Rebecca Kirkham promoted to senior vice president and chief communications and corporate affairs officer, and Reed Smith elevated to senior vice president and chief consumer officer.
In his new role, Caspers will focus on executing strategic growth initiatives, driving operational excellence, and optimizing the company's consumer-centric operating model across markets.
Ardent Health (NYSE: ARDT) reported strong Q4 2024 results, with total revenue growing 19.3% year-over-year to $1,606 million. The quarter was positively impacted by the New Mexico state directed payment program approval and recovery from a 2023 cybersecurity incident.
Key Q4 2024 metrics include:
- Net income of $114 million ($0.81 per diluted share) vs. net loss of $4 million in Q4 2023
- Adjusted EBITDA increased 213% to $183 million
- Admissions up 11.5% with strong growth in general medicine, cardiology and neurology
- Surgeries increased 6.3% year-over-year
For full-year 2024, revenue increased 10.3% to $5.97 billion, with Adjusted EBITDA growing 58.4% to $498 million. The company maintained strong liquidity with $557 million in cash and total debt of $1.1 billion. In January 2025, ARDT acquired 18 urgent care clinics from NextCare Urgent Care in New Mexico and Oklahoma.
Ardent Health (NYSE: ARDT), a leading healthcare provider in mid-sized urban communities across the U.S., announced participation in upcoming investor conferences.
The company will attend the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, in Miami, Florida. Ardent Health's management team will engage in a fireside chat at 8 a.m. ET.
Additionally, they will join the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, with a fireside chat scheduled for 9 a.m. ET.
A live audio webcast of these presentations will be accessible on the company's Investor Relations website at https://ir.ardenthealth.com, with replays available for 90 days.
Ardent Health's management will also be available for one-on-one meetings with registered investors at each conference. For further details, investors can contact their sales representative at the host firm or reach out to Dave Styblo, Ardent Health's senior vice president of investor relations, at Investor.Relations@ardenthealth.com.